Slipping COVID-19 Treatment Demand Hits Eli Lilly Forecast
Overall, Lilly's net income fell 7 percent in the quarter to $1.35 billion, with adjusted earnings totaling $1.87 per share. Revenue grew 16 percent to $6.81 billion.
Overall, Lilly's net income fell 7 percent in the quarter to $1.35 billion, with adjusted earnings totaling $1.87 per share. Revenue grew 16 percent to $6.81 billion.